VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
TRV
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
TRVThe Travelers Companies, Inc.
$343.73$73.1B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksTRVQuarterly Financials

The Travelers Companies, Inc. (TRV) Quarterly Financials

120+ quarters historyFree accessUpdated daily

The Travelers Companies, Inc. (TRV) quarterly income statement — complete revenue, gross profit & net income history

TRV Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Revenue11.92B12.43B12.47B12.12B11.81B12.01B11.9B11.28B11.23B10.94B10.63B10.1B9.7B9.64B9.31B9.14B8.81B9.01B8.8B8.69B
Revenue Growth %0.97%3.49%4.75%7.38%5.18%9.85%11.93%11.73%15.7%13.46%14.21%10.53%10.16%6.97%5.76%5.17%5.97%7.31%6.4%17.38%
Medical Costs & Claims6.38B5.83B6.59B8.59B9.78B7.84B8.79B9.05B8.35B7.52B8.75B8.75B7.42B7.36B7.49B7.17B6.35B6.12B6.75B6.3B
Medical Cost Ratio %53.52%46.91%52.88%70.91%82.85%65.27%73.81%80.22%74.4%68.77%82.3%86.61%76.47%76.34%80.48%78.46%72.07%67.92%76.6%72.51%
Gross Profit5.54B6.6B5.88B3.52B2.03B4.17B3.12B2.23B2.87B3.42B1.88B1.35B2.28B2.28B1.82B1.97B2.46B2.89B2.06B2.39B
Gross Margin %46.48%53.09%47.12%29.09%17.15%34.73%26.19%19.78%25.6%31.23%17.7%13.39%23.53%23.66%19.52%21.54%27.93%32.08%23.4%27.49%
Gross Profit Growth %173.54%58.2%88.45%57.93%-29.51%22.17%65.67%65.09%25.89%49.71%3.52%-31.3%-7.2%-21.1%-11.75%-17.59%15.17%1.76%-5.59%113.02%
Operating Expenses3.42B3.5B3.53B1.64B1.56B1.58B1.56B1.58B1.5B1.4B1.41B1.4B1.35B1.29B1.29B1.31B1.28B1.24B1.27B1.26B
OpEx / Revenue %28.71%28.13%28.32%13.57%13.19%13.14%13.09%13.97%13.4%12.77%13.26%13.86%13.96%13.42%13.85%14.35%14.51%13.77%14.47%14.47%
Depreciation & Amortization193M162M166M164M188M163M174M182M196M170M169M179M204M187M195M210M234M208M212M215M
Combined Ratio %82.23%75.04%81.2%84.48%96.04%78.41%86.9%94.19%87.8%81.54%95.56%100.48%90.44%89.76%94.33%92.81%86.58%81.69%91.07%86.98%
Operating Income2.12B3.1B2.34B1.88B468M2.59B1.56B656M1.37B2.02B472M-48M928M987M528M657M1.18B1.65B786M1.13B
Operating Margin %17.77%24.96%18.8%15.52%3.96%21.59%13.1%5.81%12.2%18.46%4.44%-0.48%9.56%10.24%5.67%7.19%13.42%18.31%8.93%13.02%
Operating Income Growth %352.78%19.62%50.26%186.74%-65.84%28.48%230.51%1466.67%47.63%104.56%-10.61%-107.31%-21.49%-40.18%-32.82%-41.91%32.66%2.1%-20.28%1430.59%
EBITDA2.31B3.27B2.51B2.04B656M2.76B1.73B838M1.57B2.19B641M131M1.13B1.17B723M867M1.42B1.86B998M1.35B
EBITDA Margin %19.39%26.26%20.13%16.88%5.55%22.95%14.57%7.43%13.95%20.02%6.03%1.3%11.67%12.18%7.76%9.49%16.07%20.62%11.33%15.49%
Interest Expense116M116M111M99M99M98M98M98M98M98M98M92M88M88M88M88M87M88M87M83M
Non-Operating Income-116M-116M-111M-99M-99M-98M-98M-98M-98M-98M-98M-92M-88M-88M-88M-88M-87M-88M-87M-83M
Pretax Income2.12B3.1B2.34B1.88B468M2.59B1.56B656M1.37B2.02B472M-48M928M987M528M657M1.18B1.65B786M1.13B
Pretax Margin %17.77%24.96%18.8%15.52%3.96%21.59%13.1%5.81%12.2%18.46%4.44%-0.48%9.56%10.24%5.67%7.19%13.42%18.31%8.93%13.02%
Income Tax408M607M456M372M73M512M300M122M247M393M68M-34M-47M168M74M106M164M317M124M197M
Effective Tax Rate %19.25%19.56%19.45%19.78%15.6%19.74%19.23%18.6%18.03%19.47%14.41%70.83%-5.06%17.02%14.02%16.13%13.87%19.21%15.78%17.42%
Net Income1.71B2.5B1.89B1.51B395M2.08B1.26B534M1.12B1.63B404M-14M975M819M454M551M1.02B1.33B662M934M
Net Margin %14.35%20.08%15.14%12.45%3.34%17.33%10.58%4.73%10%14.87%3.8%-0.14%10.05%8.5%4.88%6.03%11.56%14.79%7.52%10.75%
Net Income Growth %333.16%19.88%49.84%182.58%-64.83%28.04%211.88%3914.29%15.18%98.53%-11.01%-102.54%-4.22%-38.56%-31.42%-41.01%38.88%1.76%-19.95%2435%
EPS (Diluted)7.7811.068.246.531.708.965.422.294.816.981.74-0.064.133.441.912.294.185.372.623.66
EPS Growth %357.65%23.44%52.03%185.15%-64.66%28.37%211.49%3860.26%16.46%102.91%-8.9%-102.66%-1.2%-35.94%-27.1%-37.43%45.64%5.29%-18.89%2387.5%
EPS (Basic)7.8911.248.376.631.739.115.502.314.877.071.75-0.064.183.491.932.314.235.432.653.70
Diluted Shares Outstanding218.4M224M227.5M229.3M230.4M230.7M230.6M231.5M232M231.1M231.1M229.7M234.4M236.3M237.9M241.1M243.7M246.4M250.1M253.1M